Home
Magna Scientia Advanced Biology and Pharmacy
Peer-Reviewed • ISSN: 2582-8363 • Fast-Track Publishing • Impact Factor 8.6 • Low Publication Charges • Crossref DOI Linking

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Research and review articles are invited for publication in September - October 2026 (Volume 19, Issue 1) Submit manuscript

Laxative effect of prebiotics in chronic constipation: Mechanisms of action

Breadcrumb

  • Home
  • Laxative effect of prebiotics in chronic constipation: Mechanisms of action

Lorenzo De Fraia, Stephanos Christodoulides and Ioannis Patrikios *

European University Cyprus, School of Medicine, Cyprus.
 
Review Article
Magna Scientia Advanced Biology and Pharmacy, 2023, 09(02), 008–013
Article DOI: 10.30574/msabp.2023.9.2.0046
DOI url: https://doi.org/10.30574/msabp.2023.9.2.0046
Received on 05 May 2023; revised on 13 July 2023; accepted on 16 July 2023
 
Constipation is a condition that affects a consistent part of the general population, with increasing numbers of incidence worldwide. Its causes can be attributed to several factors. One of these factors (and one of the most relevant causes) is dietary choices. For instance, poor nutrition habits have been shown to adversely affect the function of the digestive tract, eliciting abnormal physiological responses that might lead to constipation. Prebiotics are specialized types of fermentable fibres which have been hypothesised to play a beneficial role in the treatment of chronic idiopathic constipation. Fructo-oligosaccharides (FOS), galacto-oligosaccharides (GOS) and inulin are the most common types of prebiotics. There are several studies to demonstrate that prebiotics have many interactions with the bowel and its movements, thus they are potentially beneficial in the treatment of chronic idiopathic constipation. Some prebiotics can retain water and therefore increase stool mass and viscosity, making the passage of faeces through the gastrointestinal tract easier. In addition, prebiotics can feed the probiotic bacteria (the body’s “good” bacteria that synergistically live in the digestive tract), and the fermentation of prebiotics by the probiotic bacteria leads to the production of short-chain fatty acids (SCFAs). SCFA synthesis through prebiotic fermentation has been shown to improve gastrointestinal function and bowel movement. Moreover, prebiotic fermentation in the colon might trigger both immunomodulatory responses and the production of neurotransmitters that elicit stronger contractility in the colon. Prebiotic fermentation from the gut microbiota might trigger the release of neurotransmitters that interact with the central nervous system (CNS) and enteric nervous system (ENS). These bacterial neuromodulators directly affect the digestive nerve terminals, eliciting responses from the digestive tract that result in a faster and easier defaecation. Besides the existing studies that describe the roles of prebiotics in gut health and motility, their beneficial role has not yet been fully understood and proven, thus further research is needed on the topic.
 
Constipation; Dietary fibre; Prebiotics; Gut microbiota; Short chain fatty acids; Mechanisms
 
https://msabp.magnascientiapub.com/sites/default/files/fulltext_pdf/MSABP-2023-…

Preview Article PDF

Lorenzo De Fraia, Stephanos Christodoulides and Ioannis Patrikios. Laxative effect of prebiotics in chronic constipation: Mechanisms of action. Magna Scientia Advanced Biology and Pharmacy, 2023, 9(2), 008-013. Article DOI: https://doi.org/10.30574/msabp.2023.9.2.0046

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 Magna Scientia Advanced Biology and Pharmacy - All rights reserved

Developed & Designed by VS Infosolution